LABS vs. CWEB, MDP, WLLW, VPH, CTX, and APS
Should you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include Charlotte's Web (CWEB), Medexus Pharmaceuticals (MDP), Willow Biosciences (WLLW), Valeo Pharma (VPH), Crescita Therapeutics (CTX), and Aptose Biosciences (APS). These companies are all part of the "medical" sector.
Charlotte's Web (TSE:CWEB) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, community ranking, risk and analyst recommendations.
MediPharm Labs has lower revenue, but higher earnings than Charlotte's Web. MediPharm Labs is trading at a lower price-to-earnings ratio than Charlotte's Web, indicating that it is currently the more affordable of the two stocks.
In the previous week, Charlotte's Web and Charlotte's Web both had 2 articles in the media. Charlotte's Web's average media sentiment score of 0.47 beat MediPharm Labs' score of 0.20 indicating that MediPharm Labs is being referred to more favorably in the news media.
MediPharm Labs received 25 more outperform votes than Charlotte's Web when rated by MarketBeat users. Likewise, 65.79% of users gave MediPharm Labs an outperform vote while only 0.00% of users gave Charlotte's Web an outperform vote.
Charlotte's Web has a net margin of -37.68% compared to Charlotte's Web's net margin of -39.57%. Charlotte's Web's return on equity of -24.00% beat MediPharm Labs' return on equity.
Charlotte's Web has a beta of 2.23, indicating that its share price is 123% more volatile than the S&P 500. Comparatively, MediPharm Labs has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.
5.2% of Charlotte's Web shares are held by institutional investors. Comparatively, 0.7% of MediPharm Labs shares are held by institutional investors. 11.2% of Charlotte's Web shares are held by company insiders. Comparatively, 2.5% of MediPharm Labs shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
MediPharm Labs beats Charlotte's Web on 8 of the 14 factors compared between the two stocks.
Get MediPharm Labs News Delivered to You Automatically
Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MediPharm Labs Competitors List
Related Companies and Tools
